ADA and Bartsocas-Papas syndrome 1: This immunological reaction to BPs is not fully understood and the fraction of patients developing anti-drug antibodies (ADA) has varied from 2 to 47%, depending upon either the product or the laboratory methods and cut-off used to define antibody positivity [1].